Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a simple spray make heart surgery safer?

NCT ID NCT06395727

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether numbing the airway with lidocaine spray before anesthesia can reduce dangerous blood pressure swings in heart surgery patients. 106 adults having elective cardiac surgery were enrolled. The goal was to lower opioid doses and keep the heart stable during the critical induction phase.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
lidocaine
What this could lead to
If it works, this could lead to safer anesthesia with fewer side effects for heart surgery patients.
What could go wrong
This is a small, completed Phase 4 study, so results may not apply to all patients. The technique may not work for everyone and could have rare allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

106 people

The number who actually took part.

Started

Apr 2024

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * • Undergoing elective cardiac surgery. * Age: above 18 Exclusion Criteria: * • Pregnant or breast-feeding women * Emergency surgery * Anticipated difficult airway * Allergy to any of the drugs used in the study * Cannot cooperate to complete topical anaesthesia (with mental disorders or unable to communicate) * Use of a left ventricular assist device, IAB or ECMO prior to surgery * Presence of aortic dissection * EF\<40 % * Severe mitral valve stenosis or severe aortic valve stenosis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Abdallah

    Cairo, 02, Egypt

  • Abdallah Mahmoud Zaki Soudi

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.